Related Experiment Video
Updated: Mar 16, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Budd-Chiari Syndrome in a Patient with Hepatitis C
Joseph Frankl1, Charles Hennemeyer2, Michael S Flores3
1University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Insights
Budd-Chiari syndrome, a liver disease, can mimic other chronic liver conditions. This case highlights its identification during a procedure for cirrhosis, emphasizing the need to consider secondary causes of portal hypertension.
Area of Science:
- Hepatology
- Vascular Medicine
- Interventional Radiology
Background:
- Chronic Budd-Chiari syndrome can present with cirrhosis, mimicking other chronic liver diseases.
- Portal hypertension management can be challenging, necessitating consideration of underlying or coexisting conditions.
- Hepatocellular carcinoma may coexist with other primary liver pathologies.
Purpose of the Study:
- To report a case of Budd-Chiari syndrome initially misdiagnosed as hepatitis C-related cirrhosis.
- To illustrate the successful management of Budd-Chiari syndrome with angioplasty.
- To emphasize the importance of identifying secondary causes of portal hypertension.
Main Methods:
- Transjugular intrahepatic portosystemic shunting (TIPS) attempted in a patient with decompensated cirrhosis.
- Diagnosis of Budd-Chiari syndrome confirmed via venography, revealing hepatic venous webs.
- Angioplasty performed to address hepatic venous webs and relieve portal hypertension.
- Follow-up venography and liver biopsy to assess treatment efficacy and confirm etiology.
Main Results:
- Budd-Chiari syndrome, caused by hepatic venous webs, was identified as the primary disease.
- Angioplasty successfully resolved symptoms of portal hypertension.
- Follow-up venography confirmed sustained patency of hepatic veins 5 months post-procedure.
- Liver biopsy revealed centrilobular fibrosis, supporting venous occlusion as the cause of cirrhosis.
Conclusions:
- Budd-Chiari syndrome should be considered in patients with difficult-to-manage portal hypertension, even with suspected alternative etiologies like hepatitis C.
- Interventional radiology techniques, such as angioplasty, can effectively treat Budd-Chiari syndrome.
- Accurate diagnosis of primary liver pathology is crucial for effective patient management and treatment outcomes.
Abstract:
Chronic Budd-Chiari syndrome can present with cirrhosis and signs and symptoms similar to those of other chronic liver diseases. We present a case of Budd-Chiari syndrome discovered during attempted transjugular intrahepatic portosystemic shunting in a patient with decompensated cirrhosis believed to be secondary to hepatitis C. Although the patient had hepatocellular carcinoma, the Budd-Chiari syndrome was a primary disease due to hepatic venous webs. Angioplasty was performed in this case, which resolved the patient's symptoms related to portal hypertension. Follow-up venography 5 months after angioplasty demonstrated continued patency of the hepatic veins. A biopsy was obtained in the same setting, which showed centrilobular fibrosis indicating that venous occlusion was indeed the cause of cirrhosis. It is important to consider a second disease when treating a patient with difficult to manage portal hypertension.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

